Loading data
HCINYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 900.95 m USD | 750.05 m USD | 550.67 m USD | 499.56 m USD | 407.92 m USD |
| Interest expense | — | 2 k USD | 150 k USD | — | — |
| Profit before tax | 429.33 m USD | 173.43 m USD | 117.65 m USD | -68.42 m USD | 11.23 m USD |
| Income tax expense | 108.94 m USD | 45.85 m USD | 28.39 m USD | -13.82 m USD | 3.99 m USD |
| Net income (reported basis) | 320.4 m USD | 127.58 m USD | 89.26 m USD | -54.6 m USD | 7.24 m USD |
| Net income attributable to common shareholders | 286.96 m USD | 105.84 m USD | 76.41 m USD | -55.05 m USD | 1.83 m USD |
| Basic earnings per share | 24.58 USD/share | 10.59 USD/share | 9.13 USD/share | -6.24 USD/share | 0.23 USD/share |
| Diluted earnings per share | 22.72 USD/share | 8.89 USD/share | 7.62 USD/share | -6.24 USD/share | 0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.